This digital document is an article from Biotech Business, published by Worldwide Videotex on May 1, 2002. The length of the article is 730 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: FDA GRANTS AVICENA ORPHAN-DRUG DESIGNATION FOR CREATINE.
Publication:Biotech Business (Newsletter)
Date: May 1, 2002
Publisher: Worldwide Videotex
Volume: 15 Issue: 5 Page: NA
Distributed by Thomson Gale
FDA GRANTS AVICENA ORPHAN-DRUG DESIGNATION FOR CREATINE.: An article from: Biotech Business
📄 Viewing lite version
Full site ›
Book Details
PublisherWorldwide Videotex
ISBN / ASINB0008F3XQK
ISBN-13978B0008F3XQ9
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸